CHRS
Coherus Onco (CHRS)
NASDAQ
$1.53+$0.06 (+4.01%)
Price as of Jul 14, 2026 8:37 AM EDT
  • $226.7M
    Market Cap
  • 54.79%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

N/A
Valuation
CHRS
vs History
vs S&P 500
Profitability
1
Growth
0
Low Earnings Volatility
5

Momentum Score

Score: 54
Valuation
CHRS
vs History
vs S&P 500
3-Month Momentum
-20.00%
12-Month Momentum
54.55%
3-Month Risk Adjusted Momentum
-70.74%
12-Month Risk Adjusted Momentum
68.63%

True Yield

N/A
Valuation
CHRS
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
N/A
Net Debt Paydown Yield
-0.06%

Financial Health Score

N/A
Valuation
CHRS
vs History
vs S&P 500
Ohlson's O-Score
8